FrancophonIA/ELRC3.0 huggingface dataset:
English: Because Ivabradine JensonR is a generic medicine, studies in people have been limited to tests to determine that it is bioequivalent to the reference medicine, Procoralan.
Danish: Da Ivabradine JensonR er et generisk lægemiddel, har patientundersøgelserne været begrænset til at påvise, at det er bioækvivalent med referencelægemidlet Procoralan.
English: Other information about Ivabradine JensonR
Danish: Andre oplysninger om Ivabradine JensonR
English: For practical information about using Ivabradine JensonR, patients should read the package leaflet or contact their doctor or pharmacist.
Danish: Hvis du ønsker praktisk vejledning om anvendelsen af Ivabradine JensonR, kan du læse indlægssedlen eller kontakte din læge eller dit apotek.
English: What are the benefits and risks of Ivabradine JensonR?
Danish: Hvilken fordel og risiko er der forbundet med Ivabradine JensonR?
English: Ivabradine JensonR therefore reduces or prevents the symptoms of angina.
Danish: Derved mindsker eller forhindrer Ivabradine JensonR anginasymptomerne.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Ivabradine JensonR have been included in the summary of product characteristics and the package leaflet.
Danish: Der er anført anbefalinger og forholdsregler i produktresuméet og indlægssedlen, som patienter og sundhedspersonale skal følge for at sikre risikofri og effektiv anvendelse af Ivabradine JensonR.
English: Why is Ivabradine JensonR approved?
Danish: Hvorfor blev Ivabradine JensonR godkendt?
English: How has Ivabradine JensonR been studied?
Danish: Hvordan blev Ivabradine JensonR undersøgt?
English: How is Ivabradine JensonR used?
Danish: Hvordan anvendes Ivabradine JensonR?
English: How does Ivabradine JensonR work?
Danish: Hvordan virker Ivabradine JensonR?
English: The updated guidelines were established during the Maastricht 22000 Consensus meeting.
Danish: De ajourførte retningslinjer blev vedtaget på konsensusmødet Maastricht 22000.
English: These gastro-resistant capsules are available in blister packs containing 7, 14, 28, 56 or 98 capsules.
Danish: Disse gastro-resistente kapsler forefindes i blisterpakninger indeholdende 7, 14, 28, 56 eller 98 kapsler.
English: Always take Lansoprazol-ratiopharm exactly as your doctor has told you.
Danish: Tag altid Lansoprazol-ratiopharm nøjagtigt som din læge har givet dig besked på.
English: Like all medicines, Lansoprazol-ratiopharm can cause side effects, although not everybody gets them.
Danish: Som alle lægemidler kan Lansoprazol-ratiopharm medføre bivikninger, selvom ikke alle får dem.
English: Lansoprazol-ratiopharm should be taken on an empty stomach (before meals).
Danish: Lansoprazol-ratiopharm bør tages på en tom mave (inden måltiderne).
English: Do not use Lansoprazol-ratiopharm after the expiry date which is stated on the carton and the blister.
Danish: Anvend ikke Lansoprazol-ratiopharm efter udløbsdatoen, der er angivet på æsken og blisterpakningen.
English: If you have the impression that the effect of Lansoprazol-ratiopharm is too strong or too weak, please talk to your doctor.
Danish: Hvis du har indtryk af, at virkningen af Lansoprazol-ratiopharm er for kraftig eller for svag, så snak med din læge.
English: Lansoprazol ratiopharm has minor or moderate influence on the ability to drive and use machines.
Danish: Lansoprazol ratiopharm har mindre eller moderat indvirken på evnen til at køre og betjene maskiner.
English: Lansoprazol ratiopharm 15 mg, 30 mg, gastro-resistant capsules, hard were referred for arbitration according to Article 29 of Council Directive 2001/83/EC, as amended, following concerns raised by Germany and Portugal during a Mutual Recognition Procedure with Finland acting as Reference Member state.
Danish: Lansoprazol ratiopharm 15 mg, 30 mg, gastro-resistente kapsler, hårde, blev indbragt til voldgiftsafgørelse i henhold til artikel 29 i Rådets direktiv 2001/83/EF, med senere ændringer, efter at der var rejst spørgsmål af Tyskland og Portugal under en procedure om gensidig anerkendelse med Finland som referencemedlemsstat.
English: This dosage recommendation for lansoprazole corresponds with the last available Consensus Report of the European Helicobacter Pylori Study Group.
Danish: Denne anbefalede dosis for lansoprazol er i overensstemmelse med den seneste konsensusapport udgivet af European Helicobacter pylori Study Group.
English: Please consult your doctor before taking Lansoprazol-ratiopharm if you know that you are intolerant to certain sugars.
Danish: Snak med din læge, inden du tager Lansoprazol-ratiopharm, hvis du ved, at du er intolerant overfor visse sukkerstoffer.
English: If you forget to take Lansoprazol-ratiopharm Do not take a double dose to make up for a forgotten dose.
Danish: Hvis du glemmer at tage Lansoprazol-ratiopharm Lad være med at tage en dobbelt dosis for at erstatte en glemt dosis.
English: This leaflet was last approved in {MM/YYYY}.
Danish: Denne indlægsseddel er sidst godkendt den {MM/ÅÅÅÅ}.
English: No further clinical data are needed to substantiate.
Danish: Der er ikke behov for yderligere kliniske oplysninger for at dokumentere dette.
English: Austria ratiopharm Arzneimittel Vertriebs -GmbH Albert-Schweitzer-G. 3 1140 Vienna Austria
Danish: Østrig ratiopharm Arzneimittel Vertriebs -GmbH Albert-Schweitzer-G. 3 1140 Wien
English: There is no need and it is not planned to reduce the dosage to 15 mg 2 times daily.
Danish: Der er hverken behov for eller planer om at nedsætte doseringen på 15 mg to gange dagligt.
English: The effect of Lansoprazol-ratiopharm may be influenced by the following medicines or drug groups:
Danish: Virkningen af Lansoprazol-ratiopharm kan blive påvirket af følgende lægemidler eller lægemiddelgrupper.
English: The effect of the following medicines or drug groups may be influenced by Lansoprazol-ratiopharm if they are used at the same time:
Danish: Virkningen af følgende lægemidler eller lægemddelgrupper kan blive påvirket af Lansoprazolratiopharm, hvis de anvendes på samme tid.
English: Important information about some of the ingredients of Lansoprazol-ratiopharm This medicine contains sucrose.
Danish: Vigtige oplysninger om nogen af indholdsstofferne i Lansoprazol-ratiopharm Dette lægemiddel indeholder sukrose.
English: If you take more Lansoprazol-ratiopharm than you should you should always consult a doctor.
Danish: Hvis du tager mere Lansoprazol-ratiopharm end du skulle Du bør altid tale med en læge.
English: Use of Lansoprazol-ratiopharm is not recommended during pregnancy.
Danish: Brug af Lansoprazol-ratiopharm anbefales ikke under graviditet.
English: Taking Lansoprazol-ratiopharm with food and drink:
Danish: Indtagelse af Lansoprazol-ratiopharm med mad og drikke:
English: Patients with severely impaired liver function should not take Lansoprazol-ratiopharm, nor should they be given combination therapy with clarithromycin.
Danish: Patienter med kraftig nedsat leverfunktion bør ikke tage Lansoprazol-ratiopharm, og de bør heller ikke få kombinationsbehandling med clarithromycin.
English: It is recommended that you take Lansoprazol-ratiopharm before meals, as simultaneous food intake reduces the availability of lansoprazole to the body.
Danish: Det anbefales, at du tager Lansoprazol-ratiopharm inden måltiderne, da samtidig fødeindtaelse nedsætter tilgængeligheden af lansoprazol til kroppen.
English: Eradication of H. pylori and peptic ulcer healing (15 mg dosage form) According to the proposed SmPC (> day 60), section 4.2, the recommended dose for H. pylori eradication is 30 mg twice daily.
Danish: Udryddelse af H. pyolori og heling af peptisk ulcus (15 mg doseringsform) I overensstemmelse med det foreslåede produktresumée (> dag 60), afsnit 4.2, er den anbefalede dosis for udryddelse af H. pylori 30 mg to gange dagligt.
English: Lansoprazol-ratiopharm is a medicine which reduces the amount of acid made by the stomach (selective proton pump inhibitor).
Danish: Lansoprazol-ratiopharm er en medicin, der nedsætter mængden af syre, der laves af maven (selektiv protonpumphæmmer).
English: In case of clarithromycin resistance, or treatment failure, the combination of lansoprazole-amoxicillinmetronidazole may be used, and in case of beta-lactam allergy the combination of lansoprazoleclarithromycin-metronidazole is advisable.
Danish: I tilfælde af resistens over for clarithromycin eller fejlslagen behandling kan der anvendes en kombination af lansoprazol-amoxicillin-metronidazol, og i tilfælde af allergi over for beta-lactam er det tilrådeligt at anvende en kombination af lansoprazol-clarithromycin-metronidazol.
English: In patients with cirrhosis theAUC of lansoprazole is significantly increased and the elimination half-life is prolonged, but no signs of accumulation of lansoprazole have been detected.
Danish: Hos patienter med skrumpelever er AUC for lansoprazol signifikant øget, og eliminationshalveringstiden er forlænget, men der er ikke fundet nogen tegn på akkumulering af lansoprazol.
English: You should avoid breastfeeding while taking Lansoprazol-ratiopharm, as there has been insufficient experience with its use during lactation.
Danish: Du bør undgå at amme, mens du tager Lansoprazol-ratiopharm, da der er utilstrækkelig erfaring med dets brug under amning.
English: Intake of Lansoprazol-ratiopharm may mask the symptoms of a tumour and delay diagnosis of this condition
Danish: Indtagelse af Lansoprazol-ratiopharm kan maskere symptomerne på en tumor og forsinke diagnosen af denne tilstand.
English: If you take too low a dose, if you take your medicine irregularly or if you stop your treatment prematurely, this may endanger the success of your treatment or may cause relapses which are more difficult to treat.
Danish: Hvis du holder op med at tage Lansoprazol-ratiopharm Hvis du tager for lav en dosis, hvis du tager din medicin uregelmæssigt, eller hvis du stopper di behanling for tidligt, kan dette sætte den heldige gennemførelse af din behandling på spil eller kan medføre tilbagefald, der er vanskeligere at behandle.
English: BEFORE YOU TAKE Lansoprazol-ratiopharm Do not take Lansoprazol-ratiopharm - if you are allergic (hypersensitive) to Lansoprazol or any of the other ingredients of Lansoprazol-ratiopharm.
Danish: Lad være med at tage Lansoprazol-ratiopharm - hvis du er allergisk (overfølsom) overfor Lansoprazol eller nogen af de andre ingredienser i
English: The recommended dosage can be fulfilled by administering one capsule of 30 mg or two capsules of 15 mg twice daily, because the composition of the content of one capsule with 30 mg lansoprazole is exactly the same as the composition of the content of two capsules with 15 mg lansoprazole, as “Description and Composition of the Drug Product” (3.2.P1) of both strengths show
Danish: Den anbefalede dosering kan opnås ved indgivelse af en kapsel à 30 mg eller to kapsler à 15 mg to gange dagligt, da sammensætningen af indholdet i en kapsel à 30 mg lansoprazol er nøjagtig den samme som sammensætningen af indholdet i to kapsler à 15 mg lansoprazol, hvilket fremgår af Description and Composition of the Drug Product” (3.2.P1).
English: NAME OF THE MARKETING AUTHORISATION HOLDER ratiopharm GmbH [see Annex I - to be completed nationally]
Danish: NAME OF THE MARKETING AUTHORISATION HOLDER ratiopharm GmbH [se Bilag I - udfyldes nationalt]
English: Fluvoxamine (a medicine for the treatment of depression), ketoconazole and itraconazole (medicines for the treatment of fungal infections), protease inhibitors (active substances used in the treatment of the AIDS virus) and macrolides (certain types of antibiotics) may markedly raise the concentration of lansoprazole in the blood and thus increase the effect of Lansoprazol-ratiopharm.
Danish: Fluvoxamin (et lægemiddel til behandling af depression), ketoconazol og itraconazole (lægemidler til behandling af svampeinfektioner), proteasehæmmere (aktive substanser anvendt til behandling af AIDS virus) og makrolider (visse typer antibiotika) kan mærkbart øge koncentrationen af lansoprazol i blodet og dermed øge virkningen af Lansoprazol-ratiopharm.
English: Lansoprazol-ratiopharm may not be used in children, as its safety and efficacy have not been established in this patient group.
Danish: Lansoprazol-ratiopharm må ikke anvendes til børn, da dets sikkerhed og virkning ikke er blevet fastslået hos denne patientgruppe.
English: During treatment with Lansoprazol-ratiopharm, side effects such as light-headedness and fatigue may occur (see section 4.
Danish: Under behandling med Lansoprazol-ratiopharm kan der forekomme bivirkninger såsom svimmelhed og træthed (se pkt.
English: The concerns rose referred to discrepancies in comparison to the reference products on posology triple therapy for H. pylori eradication and indication of the 15 mg dosage form.
Danish: Spørgsmålene vedrørte afvigelser i forhold til referenceprodukterne med hensyn til doseringen i den tredobbelte behandling til udryddelse af H. pylori og indikationen for doseringsformen 15 mg.
English: The appropriate dosing will be possible with 30 mg capsules as well as with 15 mg capsules and therefore, a risk to public health with the use of the 15 mg strength for eradication therapy is not seen.
Danish: En korrekt dosering er mulig med 30 mg kapsler og 15 mg kapsler, og derfor anses en styrke på 15 mg til eradikationsbehandling ikke for at udgøre en risiko for den offentlige sundhed.
English: GROUNDS FOR AMENDMENT OF THE SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET Whereas, ¾ The scope of the referral was to agree on a harmonised the dosing schedule for triple therapy for eradication therapy for H. pylori.
Danish: BEGRUNDELSER FOR ÆNDRING AF PRODUKTRESUMÉ, ETIKETTERING OG INDLÆGSSEDDEL Ud fra følgende betragtninger: ¾ formålet med indbringelsen af sagen var at harmonisere doseringsplanen for den tredobbelte eradikationsbehandling af H. pylori.
English: When making a decision as to whether breastfeeding or therapy with Lansoprazol-ratiopharm should be continued or discontinued, the benefits of breastfeeding for the child and the benefits of therapy with Lansoprazol-ratiopharm for the mother should be considered.
Danish: Når der skal tages beslutning om der skal fortsættes eller afbrydes med amning eller behandling med Lansoprazol-ratiopharm, bør fordelene ved amning for barnet og fordelene ved behandling med Lansoprazol-ratiopharm for moderen overvejes.
English: Eradication of H. pylori and peptic ulcer healing (posology) In order to standardise the treatment regimens for H. pylori eradication guidelines on the management of Helicobacter pylori infection were published by the European Helicobacter pylori Study Group.
Danish: Udryddelse af H. pylori og heling af peptisk ulcus (dosering) Med det formål at harmonisere behandlingerne til udryddelse af Helicobacter pylori blev der offentliggjort retningslinjer for behandling af Helicobacter pylori- infektion af European Helicobacter pylori Study Group.
English: - Before treatment with Lansoprazol-ratiopharm - the diagnosis of ulcers of the duodenum or stomach and inflammation of the gullet due to reflux of stomach acid should be confirmed by gastroscopy or other appropriate diagnostic measures (e.g. X-ray with contrast media) - a stomach ulcer with Lansoprazol-ratiopharm, the possibility of a malignant stomach tumour should be excluded.
Danish: - Inden behandling med Lansoprazol-ratiopharm - bør diagnosen på sår i duodenum eller mavesækken og inflammation af spiserøret på grund af refluks af mavesyre bekræftes ved gastroskopi eller andre passende diagnostiske tiltag (f.eks. røntgen med kontrastmiddel) - af et mavesår med Lansoprazol-ratiopharm, bør muligheden for en malign mavetumor udelukkes.
English: The risk/benefit ratio of Lansoprazol ratiopharm 15 mg, 30 mg is considered to be favourable provided that appropriate information regarding H. pylori eradication therapy are included in the SPC.
Danish: Lansopon 15 mg, 30 mg udviser et gunstigt benefit/risk-forhold, forudsat at der indføjes passende oplysninger vedrørende eradikationsbehandlingen for H. pylori i produktresuméet.
English: At the beginning or end of simultaneous use of Lansoprazol-ratiopharm, plasma tacrolimus concentrations should be monitored.
Danish: Ved start eller afsluning af samtidig anvendelse af Lansoprazol-ratiopharm, bør plasmakoncentrationer for tacrolimus overvåges.
English: Ketoconazole and itraconazole (medicines for the treatment of fungal infections) The combination of lansoprazole and ketoconazole or itraconazole should be avoided, as the reduction in stomach acid caused by intake of Lansoprazol-ratiopharm may impair the absorption of the other medicines into the blood, thus leading to an underdose.
Danish: Kmbinationen af lansoprazol og ketoconazol eller itraconazol bør undgås, da reduktionen af mavesyre på grund af indtagelse af Lansoprazol-ratiopharm kan forringe absorptionen af de andre lægemidler blodet og dermed lede til en underdosering.
English: Lansoprazol-ratiopharm is not recommendes for use in children, as its safety and efficacy have not been established in this patient group.
Danish: Lansoprazol-ratiopharm anbefales ikke til børn, da dets sikkerhed og virkning ikke er blevet fastslået hos denne patientgruppe.
English: OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF LANSOPRAZOL RATIOPHARM 15 MG, 30 MG, GASTRO-RESISTANT CAPSULES, HARD (see Annex I)
Danish: SAMLET RESUMÉ AF DEN FAGLIGE VURDERING AF LANSOPRAZOL RATIOPHARM 15 MG, 30 MG, GASTRO-RESISTENTE KAPSLER, HÅRDE (se bilag I)
English: INFORMATION IN BRAILLE < Lansoprazol-ratiopharm 30 mg > [to be completed nationally]
Danish: INFORMATION I BRAILLE < Lansoprazol-ratiopharm 30 mg > [udfyldes nationalt]
English: For those therapeutic indications in which a daily dose exceeding 15 mg lansoprazole is specified, gastro-resistant hard capsules containing 30 mg of medically active ingredient are also available.
Danish: For de behandlingsmæssige indiktioner, hvor en daglig dosis, der overstiger 15 mg lansoprazol, er specificeret, findes der også gastro-resistete hårde kapsler indeholdende 30 mg medicinsk aktivt indholdsstof.
English: Lansoprazol-ratiopharm capsules are swallowed whole with sufficient liquid (e.g. a glass of water).
Danish: Lansoprazol-ratiopharm kapsler synkes hele med tilstrækkelig væske (f.ek.
English: Co-administration of lansoprazole increases the plasma concentrations of tacrolimus (a CYP3A and Pgp substrate).
Danish: Tacrolimus Samtidig administration af lansoprazol øger plasmakoncentrationerne af tacrolimus (et CYP3A og P
English: WHAT Lansoprazol-ratiopharm IS AND WHAT IT IS USED FOR
Danish: HVAD ER Lansoprazol-ratiopharm OG HVAD ANVENDES DET TIL
English: • amoxicillin, 500 mg three times daily, + metronidazole, 400 mg three times daily (advisable when clarithomycin resistance is likely)
Danish: • amoxicillin, 500 mg tre gange dagligt, + metronidazol, 400 mg tre gange dagligt (tilrådeligt, når der er sandsynlighed for resistens over for clarithomycin )
English: Do not store above 30°C.
Danish: Må ikke opbevares ved over 30ºC.
English: What Lansoprazol-ratiopharm looks like and contents of the pack
Danish: Hvorledes Lansoprazol-ratiopharm ser ud og indholdet af pakningen
English: Treatment with Lansoprazol-ratiopharm therefore leads to a slightly increased risk of infections in the gastrointestinal tract, such as with salmonella and Campylobacter.
Danish: Behandling med Lansoprazol-ratiopharm leder derfor til en let øget risiko for infektioner i mave-tarmkanalen, såsom med salmonella og Campylobacter.
English: Blood and lymphatic system disorders
Danish: urinvejsmæssig e forstyrrelser Forstyrrelser i blod og lymfesystem
English: How to store Lansoprazol-ratiopharm Further information
Danish: Opbevaring af Lansoprazol-ratiopharm Yderligere oplysninger
English: Lansoprazol-ratiopharm is given:
Danish: Lansoprazol-ratiopharm bliver givet for:
English: What Lansoprazol-ratiopharm is and what it is used for Before you take Lansoprazol-ratiopharm How to take Lansoprazol-ratiopharm Possible side effects
Danish: Inden du tager Lansoprazol-ratiopharm Hvorledes skal Lansoprazol-ratiopharm tages Mulige bivirkninger
English: Gastro-resistant capsule, hard Oral use
Danish: 30 mg gastro-resistent kapsel, hård Oral anvendelse
English: hydroxy sulphone, 5-hydroxy sulphide and 5-hydroxy lansoprazole.
Danish: Tre metabolitter er blevet identificeret i urinen: 5-hydroxysulfon, 5-hydroxysulfid og 5-hydroxylansoprazol.
English: INFORMATION IN BRAILLE < Lansoprazol-ratiopharm 15 mg > [to be completed nationally]
Danish: INFORMATION I BRAILLE < Lansoprazol-ratiopharm 15 mg >
English: Increase bioaivalability and half-life of lansoprazole by 30 % each; increased plasma levels of a clarithromycin metabolite by 30 %
Danish: 30 mg + 500 mg + 1000 mg Øger biotilgængeligheden og halveringstiden clarithromycin + amoxicillin to gange daglig i 5 dage for lansoprazol med hver 30 %; øgede plasmaniveauer af en clarithromycin metabolit med 30 %
English: NAME OF THE MEDICINAL PRODUCT < Lansoprazol-ratiopharm and associated names (see Annex I) 15 mg magensaftresistente Hartkapseln > [see Annex I - to be completed nationally]
Danish: NAME OF THE MEDICINAL PRODUCT < Lansoprazol-ratiopharm og tilknyttede navne (se Bilag I) 15 mg gastro-resistente hårde kapsler > [se Bilag I - udfyldes nationalt]
English: What Lansoprazol-ratiopharm contains
Danish: Hvad indeholder Lansoprazol-ratiopharm
English: If you stop taking Lansoprazol-ratiopharm
Danish: INDEN DU TAGER Lansoprazol-ratiopharm
English: < Lansoprazol ratiopharm and associated names (see Annex I) 15 mg gastro-resistant hard capsules > < Lansoprazol ratiopharm and associated names (see Annex I) 30 mg gastro-resistant hard capsules >
Danish: LÆGEMIDLETS NAVN < Lansoprazol ratiopharm og tilknyttede navne (se Bilag I) 15 mg gastro-resistent hård kapsel> < Lansoprazol ratiopharm og tilknyttede navne (se Bilag I) 30 mg gastro-resistent hård kapsel > [se Bilag I - udfyldes nationalt]
English: Marketing Authorisation Holder: ratiopharm GmbH, Graf-Arco-Strasse 3, D-89079 Ulm, Germany
Danish: Indehaver af markedsføringsilladelsen: ratiopharm GmbH, Graf-Arco-Str. 3, D-89079 Ulm, Tyskland
English: ¾ The Summary of Products Characteristic, labelling and package leaflet proposed by the applicant has been assessed based on the documentation submitted and the scientific discussion within the Committee.
Danish: ¾ det af ansøgeren foreslåede produktresumé er blevet vurderet på grundlag af den forelagte dokumentation og den faglige drøftelse i udvalget anbefaler CHMP, at der udstedes markedsføringstilladelser med ændringer af produktresuméet for Lansoprazol ratiopharm og de tilknyttede navne.
English: Monitoring of tacrolimus plasma concentrations is advised when concomitant treatment with lansoprazole is initiated or ended.
Danish: Lansoprazol eksponering øgede middeleksponeringen for tacrolimus med op til 81%.Monitoring af tacrolimus plasmakoncentrationer tilrådes, når samtidig behandling med lansoprazol indledes eller afsluttes.
English: NAME OF THE MEDICINAL PRODUCT < Lansoprazol-ratiopharm and associated names (see Annex I) 30 mg magensaftresistente Hartkapseln >
Danish: LÆGEMIDLETS NAVN < Lansoprazol-ratiopharm og tilknyttede navne (se Bilag I) 30 mg gastro-restistente hårde kapsler >
English: “How to take Lansoprazol-ratiopharm”) - if you use Lansoprazol-ratiopharm in combination therapy with antibiotics to eradicate Helicobacter pylori, you should carefully read the package leaflets of these antibiotics, too - if you take Lansoprazol-ratiopharm for longer than 1 year, therapy should be regularly monitored and the doctor should carefully consider the benefit versus risk ratio - if you experience any problems with your eyesight following long-term use (longer than 1 year), treatment with Lansoprazol-ratiopharm should be promptly discontinued and you should consult an ophthalmologist.
Danish: “Hvorledes skal Lansoprazol-ratiopharm tages”) - hvis du anvender Lansoprazol-ratiopharm i kombinationsbehandling med antibiotika for at udrydde Helicobacter pylori, så skal du også omhyggeligt læse indlægssedlerne for disse antibiotika.